What is the recommended treatment for cat-scratch disease presenting with fever and lymphadenitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment for Cat-Scratch Disease with Fever and Lymphadenitis

Azithromycin is the recommended first-line treatment for cat-scratch disease presenting with fever and lymphadenitis, dosed at 500 mg on day 1 followed by 250 mg daily for 4 additional days (for patients >45 kg), or 10 mg/kg on day 1 then 5 mg/kg daily for 4 more days (for patients <45 kg). 1

Evidence-Based Rationale

The 2014 IDSA guidelines provide the strongest recommendation (strong, moderate quality evidence) for azithromycin based on the only placebo-controlled trial in cat-scratch disease. This study demonstrated that azithromycin-treated patients achieved 80% regression in lymph node size at 30 days significantly more often than placebo (P = 0.02). 1

Clinical Context

Cat-scratch disease, caused by Bartonella henselae, typically presents with:

  • A papule or pustule developing 3-30 days after cat scratch or bite
  • Regional lymphadenopathy appearing ~3 weeks after inoculation
  • Lymph node suppuration in ~10% of cases
  • Extranodal disease (CNS, liver, spleen, bone, lung) in ≤2% of cases
  • Self-limited course with lymphadenopathy resolving within 1-6 months 1

Treatment Algorithm

For Immunocompetent Patients:

Standard therapy:

  • Patients ≥45 kg: Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days
  • Patients <45 kg: Azithromycin 10 mg/kg PO day 1, then 5 mg/kg PO daily × 4 days 1

Alternative regimens (based on retrospective data, not controlled trials):

  • Rifampin: 87% efficacy in retrospective series 2
  • Ciprofloxacin: 84% efficacy in retrospective series 2, 3
  • Trimethoprim-sulfamethoxazole: 58% efficacy 2
  • Gentamicin IM: 73% efficacy 2

For Immunocompromised Patients (HIV/AIDS):

This is a different disease entity—bacillary angiomatosis:

  • Erythromycin 500 mg QID for 2 weeks to 2 months, OR
  • Doxycycline 100 mg BID for 2 weeks to 2 months 1
  • May require >3 months of therapy 4
  • Doxycycline ± rifampin for CNS involvement or severe disease 4

Important Clinical Caveats

Diagnostic Challenges:

  • B. henselae is fastidious and rarely grows from cultures
  • Serologic testing supports diagnosis but has cross-reactivity with B. quintana
  • PCR is available but not standardized
  • Warthin-Starry silver stain of lymph node tissue confirms diagnosis 1

Treatment Considerations:

Most cases do not require antibiotics: The majority of cat-scratch disease in immunocompetent hosts is self-limited and resolves without treatment. 5 However, treatment is indicated when:

  • Fever is present (as in this case)
  • Significant lymphadenopathy causes discomfort
  • Systemic symptoms are prominent
  • Extranodal involvement is suspected

Antibiotics with poor efficacy: Fourteen commonly used antibiotics showed little to no value in retrospective analysis, including penicillins and first-generation cephalosporins (which have no in vivo activity). 4, 2

Red Flags for Systemic Disease:

Patients with systemic involvement more frequently present with:

  • Persistent fever (79.4% vs. 50.3% in localized disease) 6
  • Elevated C-reactive protein (24.9 vs. 6.7 mg/L) 6
  • Constitutional symptoms (weight loss, prolonged fever) 7, 6

These patients warrant evaluation for splenic/hepatic abscesses, chorioretinitis, osteomyelitis, or other extranodal disease and may require combination antibiotic therapy. 6

Special Populations:

Pregnant women: Azoles should be avoided; use local hyperthermia for cutaneous disease or amphotericin B for severe disease. 8

Children: Same azithromycin dosing as above (weight-based). 1

Bottom Line

While cat-scratch disease often resolves spontaneously, azithromycin is the evidence-based choice when treatment is warranted for fever and lymphadenitis, supported by the only randomized controlled trial and current IDSA guidelines. The 5-day course is well-tolerated, has proven efficacy in reducing lymph node size, and addresses the clinical symptoms that prompted treatment consideration.

Related Questions

What is the appropriate antibiotic regimen for cellulitis resulting from a cat scratch?
What are the recommended antibiotic regimens for cat scratch disease in adults, children, and pregnant women?
What oral antibiotic is appropriate for cat‑scratch disease in a patient who cannot tolerate amoxicillin‑clavulanate (Augmentin)?
What antibiotics are recommended for a cat scratch with signs of infection?
What is the recommended dose of Clindamycin (Clinda) for an infected cat scratch?
Provide a concise five-line summary of the strongest arguments supporting influenza vaccination.
What are the International Classification of Diseases, 10th Revision (ICD‑10) codes for right‑sided and left‑sided hormone‑receptor‑positive breast cancer?
How should I manage a patient (taking lumateperone 42 mg daily, prazosin 2 mg at bedtime, mirtazapine 15 mg nightly with planned increase, propranolol 150 mg tablets – 1½ tablets in the morning and 1 tablet at bedtime, and lamotrigine 150 mg tablets – 1½ tablets in the morning and 1 tablet at bedtime) who needs help sleeping and requires a medication review after taking over care from the primary care physician?
Are GLP‑1 receptor agonists safe to use in a patient with Hashimoto’s thyroiditis and type 2 diabetes?
A 5-year-old child with a history of pneumonia treated as an outpatient now presents to the emergency department with severe hypoxemia (SpO₂ 85%), drowsiness, and moderate-to-severe respiratory distress; what is the next appropriate step in management?
I have an EMG (electromyography) on Thursday morning, a cardiac stress test on Friday, and a 7‑day Holter monitor, and my cardiologist did not schedule a follow‑up after my Monday visit; is this lack of a follow‑up appropriate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.